Table 2.
Atypical | Typical | Controls | ||
---|---|---|---|---|
Demographic and Clinical Features | n = 13 | n = 23 | n = 36 | P Value |
Age, mean ± SD, y | 48 ± 14 | 50 ± 11 | 39 ± 14 | .0003a |
Body mass index, median (CI), kg/m2 | 27 (26–29) | 26 (24–28) | 26 (26–30) | .43b |
Illness duration, median (CI), d | 35 (27–55) | 40 (33–51) | 40 (36–46) | .86 |
No. of lesions, median (CI) | 1 (1.06–1.8) | 1 (1.25–2.13) | 1 (1.07–1.53) | .16a |
Total lesion circumference, median (CI), mm | 300 (121–1480) | 154 (165–380) | 246 (247–464) | .38 |
Frequency of lesions above the belt, No. (%) | 6 (46) | 6 (26) | 8 (22) | .78 |
Frequency of patients with lymph node enlargement, No. (%) | 5 (38) | 12 (52) | 19 (53) | .84 |
Blood sugar levels, median (CI), mg/dl | 238 (201–301) | 293 (258–349) | 98 (101–118) | .0001 |
Failure of therapy, No. (%) | 9 (69) | 3 (13) | 16 (44) | .0017c |
aStudent t test.
bAll other values determined using the Kruskal-Wallis test.
cFisher exact test.